|
Symposium
[Free Online] Highlights of 2022 FDA Approvals
Speakers:
Elizabeth Kelley (Genentech), Karen Samy (Genentech)
Organizers:
Cyrus Khojasteh, Genentech; Shichang Miao PhD, Amgen
Date:
2023-06-20
Time:
11:30-13:40 Pacific Time
Registration fee:
0
Location:
Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2023-06-19
(it will close sooner if the seating cap is reached)
About the Topic
[Note: this event is part of the "Success Stories and Lessons Learned from Recent FDA Approvals", a joint series by PBSS and California Life Sciences (CLS). The Zoom link will be provided to the registrants 1+ days before the event]
Seminar Overview:
In this presentation, the speakers will summarize the 2022 cohort of new drugs approved by the FDA. Statistics on the overall cohort will be discussed, followed by a short summary of key features of approved drugs. the speakers will highlight case studies with interesting discovery or development stories from the cohort as well as some examples of drugs that have failed to get approvals in 2022 and discuss various reasons and their overall journey.
2023-08-17, [Free Online] The Science and Stories of Promising Biotech Startups
|
2023-09-08, [In-person] Distribution and Disposition Studies for Biotherapeutics for IND / NDA Filings: Multi-specifics, ADCs, Nucleotides, Peptide conjugates, and Protein Degraders
|
2023-09-21, [In-Person] Advances in Cancer Therapeutics
|
2023-10-06, [In-Person] Human PK and Dose Prediction for Small Molecules
|
2024-01-15, [In-Person] ADME/DMPK Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
|
|
Ads (in random order)
Submit a Text Ad
($250 for 2 months)
Origin Bioanalytical Laboratory, Inc.
Bioanalytical CRO specializing in LC-MS/MS method development, validation, non-GLP and GLP analysis to support PK/TK studies, with ocular expertise.
|
Alturas Analytics, Inc.
Expert GLP & non-GLP LC-MS/MS, GC-MS/MS bioanalytical & PK/TK analysis services of small & large molecules in any matrix. Discovery through phase IV.
|
Hypha Discovery
Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
|
BioTether Sciences
Contract development, validation and regulated testing. Advanced cell engineering. Bioanalysis of cells, genes, and proteins.
|
|
|
Allucent
Bringing innovation to Biopharma,w/ClinPharm Modeling & Simulation services to inform dose, design, modeling + development strategies.
|
Submit a Text Ad
|